About the Journal
Aim of the Journal:
The International Gastroenterology and Hepatology journal aims to serve as a comprehensive platform for the publication of high-quality, peer-reviewed research in the fields of gastroenterology and hepatology. The journal's primary objective is to advance knowledge, understanding, and clinical practice by publishing groundbreaking original research, review articles, case reports, and clinical guidelines that contribute to the diagnosis, treatment, and management of disorders related to the digestive system and liver.The journal is useful for a wide range of professionals, including gastroenterologists, hepatologists, surgeons, radiologists, pathologists, researchers, and healthcare providers involved in the care of patients with gastrointestinal and liver diseases.
Scope of the Journal:
The scope of International Gastroenterology and Hepatology covers a wide range of topics related to the gastrointestinal tract and liver, from basic research to clinical and translational studies. The journal welcomes contributions in the following areas:
- Gastroenterology:
- Disorders of the gastrointestinal tract, including the esophagus, stomach, intestines, and colon.
- Advances in diagnostic and therapeutic endoscopy.
- Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis.
- Gastrointestinal motility disorders, such as irritable bowel syndrome (IBS) and functional dyspepsia.
- Gastrointestinal cancers, including gastric, colorectal, and esophageal cancers.
- Management and treatment of peptic ulcer disease and gastrointestinal bleeding.
- Hepatology:
- Liver diseases, including hepatitis (viral, autoimmune, and alcoholic), cirrhosis, and non-alcoholic fatty liver disease (NAFLD).
- Hepatocellular carcinoma and other liver malignancies.
- Advances in liver transplantation and post-transplant management.
- Liver fibrosis and its assessment through novel biomarkers and imaging techniques.
- Portal hypertension and associated complications.
- Pancreatic and Biliary Disorders:
- Pancreatitis (acute and chronic), pancreatic cancer, and pancreatic cysts.
- Gallbladder diseases, including cholecystitis and gallstone disease.
- Biliary tract cancers and bile duct obstructions.
- Clinical Trials and Therapeutics:
- Results of clinical trials exploring new therapeutic agents and interventions for gastrointestinal and liver diseases.
- Updates on emerging pharmacological treatments, immunotherapies, and biologics in the management of gastrointestinal and hepatic conditions.
- Nutrition and Metabolism:
- The role of nutrition and metabolic processes in gastrointestinal and liver health.
- Interventions addressing malnutrition, obesity, and their link to digestive and hepatic diseases.
- Advances in parenteral and enteral nutrition in patients with gastrointestinal and liver disorders.
- Microbiome and Gut-Liver Axis:
- The impact of the gut microbiota on gastrointestinal and liver diseases.
- Research on the gut-liver axis and its influence on systemic health, including metabolic syndrome and cardiovascular diseases.
- Probiotics, prebiotics, and microbiome-targeted therapies.
- Pediatric Gastroenterology and Hepatology:
- Studies focused on gastrointestinal and liver diseases in the pediatric population, including congenital and developmental disorders.
- Pediatric gastrointestinal cancers and liver transplantation.
- Public Health, Epidemiology, and Global Perspectives:
- Epidemiological studies examining the burden of gastrointestinal and liver diseases globally.
- Public health initiatives and interventions aimed at preventing digestive and hepatic disorders.
- Global disparities in access to gastroenterological and hepatological care.
- Imaging and Diagnostics:
- Advances in imaging techniques, including endoscopic ultrasound, MRI, CT scans, and elastography for diagnosing gastrointestinal and liver conditions.
Novel biomarkers and non-invasive diagnostic methods for early detection of gastrointestinal and hepatic diseases.